secwatch / observer
8-K filed September 11, 2025, 7:59 PM ET ticker CLSDQ CIK 0001539029
other material confidence high sentiment neutral materiality 0.65

Clearside Biomedical files 1-for-15 reverse stock split, reduces authorized shares to 26.7M

Clearside Biomedical, Inc.

item 5.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Clearside Biomedical, Inc.: Filed a Certificate of Amendment to effect a 1-for-15 reverse stock split and reduce authorized shares from 400,000,000 to 26,666,666 (effective 2025-09-12).

Change
charter amendment
Effective
2025-09-12
Exact text from the filing
On September 10, 2025, Clearside Biomedical, Inc. (the “ Company ”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “ Amendment ”) with the Secretary of State of the State of Delaware to effect a one-for-fifteen (1-for-15) reverse stock split (the “ Reverse Stock Split ”) of its outstanding common stock and a reduction in the total number of authorized shares of its common stock from 400,000,000 to 26,666,666 (the “ Shares Reduction ”). The Amendment will be effective at 5:00 p.m. Eastern Time on September 12, 2025.
View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Clearside Biomedical, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-200747
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.